The Barry Family HSCI Innovation Award funds early career researchers for creative, high-impact stem cell research with strong potential for advancing therapies for human diseases.
Funder: Harvard University
Due Dates (Anticipated): September 2026 | April 2027
Funding Amounts: $250,000 total cost; one award annually; typically for one year.
Summary: Supports early career researchers at HSCI-affiliated institutions pursuing innovative stem cell research with high potential for transformative therapeutic impact.
Key Information: Only one award is made each year; unsuccessful applicants may reapply; successful applicants may not reapply.
The Barry Family Harvard Stem Cell Institute (HSCI) Innovation Award is an annual program designed to empower early career researchers to pursue bold, transformative projects in stem cell science. The award aims to stimulate highly innovative research that advances both the basic biology and clinical translation of stem cells, with the goal of developing new therapies for human diseases. Emphasis is placed on creativity, innovation, and the potential for significant impact in the field. The program is modeled after the NIH New Innovator Award and seeks to recognize unusually creative scientists at an early stage of their careers.